Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?
How long do you monitor for clinical stability?
Related Questions
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
How do you adjust dosing of rozanolixizumb for MG patients who deteriorate before the minimum re-dosing period?
How do you counsel patients on the benefits of immunotherapy for anti-MAG neuropathy?
What is your approach to managing seronegative myasthenia gravis in patients who have not responded to immunotherapy?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
Which non-pharmacologic treatments for neuropathic pain have you found most effective?
How do you counsel patients with dermatomyositis on sun protection?
How do you treat fatigue symptoms in myasthenia gravis?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?